Form 4: Oric Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Dominic Piscitelli, Chief Financial Officer of Oric Pharmaceuticals, Inc., sold 13,400 shares of common stock on September 28, 2026 for $13.53 per share.
Summary
- Option exercise/conversion: acquired 13,400 Common Stock at $4.36 ($58,424) on September 28, 2026; holds 83,228 after (Direct).
- Open-market sale: disposed of 13,400 Common Stock at $13.53 ($181,258) on September 28, 2026; holds 69,828 after (Direct).
- Option exercise/conversion: disposed of 13,400 Stock Option (right to buy) on September 28, 2026; holds 78,500 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $181,258 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Dominic Piscitelli — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Option exercise/conversion | Common Stock | 13,400 | $4 | $58.4K | 83,228 |
| 2026-09-28 | Open-market sale | Common Stock | 13,400 | $14 | $181.3K | 69,828 |
| 2026-09-28 | Option exercise/conversion | Stock Option (right to buy) | 13,400 | — | — | 78,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Option exercise/conversion (13,400 shares) |
| 2026-09-28 | Open-market sale (13,400 shares) |
| 2026-09-28 | Option exercise/conversion (13,400 shares) |
Keywords
insider transaction, Form 4, ORIC, Oric Pharmaceuticals, Inc., bearish, Dominic Piscitelli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.